ArticleCancers2022

LiMAx Prior to Radioembolization for Hepatocellular Carcinoma as an Additional Tool for Patient Selection in Patients with Liver Cirrhosis.

Catherine Leyh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.